BioSpace News Archive

TridentUSA Health Services today announced the appointment of Lori Stallings-Sicard, MBA, RN, BSN, CENP and Jane Pike-Benton, MS, RN to the newly created position of Co-Chief Clinical Officer.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present data from two of its movement disorder programs, including INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD), and opicapone, an investigational adjunct treatment for Parkinson’s disease.

Veeva Systems (NYSE:VEEV) will host the 2019 Veeva R&D Summit, Europe for more than 600 life sciences professionals and industry experts from over 145 companies registered to attend, making it the largest Veeva R&D Summit in Europe to date

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) – the narrowing of the spinal canal, which can cause compression of nearby nerves.

Dr. Eric Hoskins, Chair of the Advisory Council on the Implementation of National Pharmacare, accompanied by Mr. Vincent Dumez, Member of the Advisory Council on the Implementation of National Pharmacare, will present the final report and its recommendations to the Government of Canada.

Trial to Study Treatment of Peripheral Artery Disease with Orbital Atherectomy via Radial Access

ACell, Inc. announced that it has reached final settlement agreements with the United States Attorney’s Office for the District of Maryland and three states to resolve all civil and criminal allegations relating to the sales and marketing of the Company’s products.

Point3 Farma, a vertically integrated large-scale supplier of CBD distillate and isolate, based in Center, Colorado has announced its Vice President, Biosciences and Plant Genetics, Joe Butler, will speak on the panel, “Flower, Seed, and Stalk: Finding the Right Cultivar For Your Hemp Business,” at the Hemp Industry Daily Conference, June 13.

NASH Network, a global Centers of Excellence Network represented by leading healthcare systems in collaboration with The Kinetix Group, is committed to non-alcoholic steatohepatitis care delivery innovation with a mission to create a standard of care for NASH, a high-volume chronic condition.

ENRICH in the USA, a European Commission DG Research funded initiative, helped introduce and support a wide array of European Union tech firms and startups, during the BIO International Convention 2019 in Philadelphia, PA, and the Select USA Investment Summit in Washington, DC.